January 2013 FDA Recall Drug by Reumofan Plus Usa
D-837-2013 - Marketed without an approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Reumofan Plus Usa on January 4, 2013 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-837-2013

Reason for Recall
Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.
Initiated
01-04-2013
Reported
08-14-2013
Quantity
586 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide through internet sales.
Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.

Batch or Lot Expiration Information

Lot# : 99515, Exp 09/2016